The large secondary sale by TPG and Summit Partners, the company's two largest pre-IPO holders, removes a significant overhang but signals a potential lack of conviction at current prices. Monitor for any subsequent insider selling and watch the next quarterly earnings for any guidance changes that might explain the timing of this exit.
Price Chart
Executive Summary
LifeStance Health Group filed an 8-K reporting a secondary offering of 22,250,000 shares of common stock by its largest private equity holders (TPG and Summit Partners) at $12.29 per share, which closed on September 11, 2026. The company simultaneously repurchased 2,000,000 shares from the underwriter at the same price, receiving no proceeds from the offering. This represents a significant de-risking event as the two largest pre-IPO investors substantially reduced their positions, removing a large overhang but signaling a potential lack of conviction from insiders about near-term upside at current levels.
Key Facts
- Selling stockholders (TPG and Summit Partners) sold 22,250,000 shares of common stock at $12.29 per share.
- The company repurchased 2,000,000 shares from the underwriter at the same price, receiving no proceeds from the offering.
- The offering closed on September 11, 2026.
- TPG VIII Lynnwood Holdings Aggregation, L.P. sold 18,409,705 shares (16,754,900 public + 1,654,805 repurchased).
- Summit Partners entities sold a combined 3,840,295 shares (3,495,100 public + 345,185 repurchased).
- The underwriter was Barclays Capital Inc.
Financial Impact
Secondary offering of 22,250,000 shares at $12.29/share, with the company repurchasing 2,000,000 shares for $24,580,000. The company received no net proceeds from the offering.
Risk Factors
- Insider selling by major pre-IPO investors may signal limited near-term upside.
- The company's use of cash to repurchase shares from the offering reduces financial flexibility.
- Potential for further secondary offerings if remaining holders seek liquidity.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-389315 |
| Document: d116139d8k.htm | 0001193125-26-389315 |
| Document: d116139dex51.htm | 0001193125-26-389315 |
| Document: 0001193125-26-389315-index-headers.html | 0001193125-26-389315 |
| Document: 0001193125-26-389315-index.html | 0001193125-26-389315 |
| Document: 0001193125-26-389315.txt | 0001193125-26-389315 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 20, 2026 7d ago | Court Ruling | $12.33 $12.56 | ▲ +1.87% | ▲ +3.05% | $13.10 (+6.24%) |
Oct 16, 2026 11d ago | 8-K | $11.77 $12.22 | ▲ +3.82% | ▲ +3.49% | $13.10 (+11.30%) |
Oct 15, 2026 12d ago | Press Release | $11.74 | awaiting T+1 | — | $13.10 (+11.58%) |
Oct 5, 2026 22d ago | SC 13G/A | $12.22 $12.12 | ▼ −0.82% | ▼ −1.37% | $13.10 (+7.20%) |
Sep 22, 2026 5w ago | Institutional Cluster | $12.55 $12.08 | ▼ −3.75% | ▼ −3.02% | $13.10 (+4.38%) |
Sep 11, 2026 6w ago | 8-K | $13.38 $13.06 | ▲ +2.39% | ▲ +1.93% | $13.10 (+2.09%) |
Aug 18, 2026 10w ago | Insider Cluster | $12.83 $12.65 | ▲ +1.40% | ▲ +0.56% | $13.10 (−2.10%) |
Aug 14, 2026 10w ago | Insider Cluster | $12.55 $12.36 | ▲ +1.51% | ▲ +0.84% | $13.10 (−4.38%) |
Aug 14, 2026 10w ago | 144 | $12.42 $12.55 | ▲ +1.05% | ▲ +1.52% | $13.10 (+5.48%) |
Aug 13, 2026 10w ago | Insider Cluster | $12.42 $12.55 | ▼ −1.05% | ▼ −1.52% | $13.10 (−5.48%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers